Characteristic of immune response of hepatitis B immunization on infants with two different schedules

  • Edy Muhammad Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Rita Carmelia Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Yuliati Yuliati Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Iskandar Z. Lubis Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • S. M. Manoeroeng Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
DOI: https://doi.org/10.14238/pi41.4.2001.197-201
Keywords: hepatitis B, immune response, immunization

Abstract

Hepatitis B immunization gives protection to hepatitis B disease. The purpose of this study was to assess the immune response of hepatitis B immunization on infants with 0,2,9 and 3,4,9 months of age schedule. The study was performed cross sectionally at the Child Health clinic of Social Pediatric sub division H. Adam Malik Hospital from November 1st 1998 until February 28th 1999. The anti HBs responses were examined in blood by ELISA method one month after the third immunization at the Clinical Pathology Division FK-USU/H. Adam Malik Hospital. Protective immune response defined if the anti HBs level ³ 10 mIU/ml. Nutritional status of infants were grouped according to the NCHS classification. The result obtained were statistically tested by Fisher exact test and t-test, on the level of significance p < 0.05. Twenty six (86.7%) of the infants had protective immune response and there were no significant difference on the level of immune response among these two groups. Gender and nutritional status seems to have no influence on the anti HBs level. In Conclusion, hepatitis B immunization either with 0,2,9 or 3,4,9 months of age schedule obtained the same immune response.

References

1. Goldwater PN. Hepatitis B vaccination: present and future. Medical progress 1987; 7:11-7.
2. Blumberg. Public Health Re, 1980, 427-95, WHO. Fauzah. Daya kebal setelah imunisasi Hepatitis B. Medika 1997; 6:451-7.
3. Julitasari, Ahmadi UF. Permasalahan penyakit hepatitis virus di Indonesia. In: Zulkarnain Z, Bisanto J, Pujiarto PS, Oswari H, editors. Tinjauan komprehensif hepatitis virus pada anak. Naskah lengkap Pendidikan Kedokteran Berkelanjutan Ilmu Kesehatan Anak FKUI XVIII. FKUI; 2000 31 Mei; Jakarta : Balai Penerbit FKUI, 2000. p. 1-7
4. Wiryo H. Hepatitis B : strategi pencegahan dan pelaksanaan imunisasi di lapangan. Presented at Pendidikan Kedokteran Berkelanjutan Ilmu Kesehatan Anak VII Fakultas Kedokteran Universitas Indonesia, Jakarta, November 6-7, 1992. Balai Penerbit FKUI, 1992. p. 87-108.
5. Elliot TC. Hepatitis B direction. Program for appropriate technology in health (PATH) 1986; 6:1-12.
6. Gunawan S. Hepatitis B dan pencegahannya melalui imunisasi di Indonesia. Cermin Dunia Kedokteran 1991; 68:5-7.
7. Wiharta AS. Strategi mutakhir vaksinasi Hepatitis B. presented at HUT RSPP XXII. Jakarta, December 11, 1993. p. 95-107
8. Wiharta AS. Strategi vaksinasi Hepatitis B pada anak. Naskah lengkap PKB-IKA XXVII FKUI. Jakarta : 6-7 November 1992. p. 119-27.
9. Lubis I. Masalah Hepatitis B surface antigen. Medika 1985; 8:789-91.
10. West DJ, Calandra GB, Hesley TM, loli V, Miller WJ. Control of hepatitis B through routine immunizations of infants : the need for flexible schedules and new combination
veccine formulations. Vaccine 1993; 11:S21-7.
11. Direktorat EPIM & PLP DEPKES RI. Petunjuk tehnis pelaksanaan imunisasi Hepatitis B. Edisi ke-2. Jakarta, April 1996.
12. Sulaiman A, Julitasari. Vaksin hepatitis B : Strategi penggunaanya di Indonesia. Virus hepatitis A sampai E di Indonesia. Jakarta : Yayasan penerbit IDI. 1995 p. 62-75.
13. Lubis IZ. Vaksinasi hepatitis B pada bayi dan anak. Majalah Muhammad et al.: Immune respons in hepatitis-B immuniuzation 201 Kedokteran Nusantara 1990 ;3:157-64.
14. Alisjahbana A, Vranckx R, Ngantung W, Sugita E, Sukadi A, Usman A,et al. Immune respone and efficacy of recombinant DNA hepatitis B vaccine in the newborns. Post graduate medical journal 1987;63:139-41
15. Chirico G, Belloni C, Gasparoni A, Cerbo RM, Rondini G, Klersy C et al. Hepatitis B immunization in infants of hepatitis B surface antigen-negative mother. Pediatrics 1993 :717-9.
16. Jilg W, Schmidt M, Zoulek G, Lorbeer B, Wilske B, Deinhardt F. Clinical evaluation of recombinant hepatitis B veccination. Lancet 1984; 24:1174-5.
17. Poovorawan Y, Sanvapat S, Pongpunglert W, Chumdermapadetsuk S, Sentrakul P, Vandepapeliere P et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992; 11:816-21.
18. Kayserling HL, West DJ, Hesley TM, Bosley C, Wlens BL, Calandra GB. Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two,
four and twelve or fifteen months of age. J Pediatr 1994; 125:67-9.
Published
2006-08-30
How to Cite
1.
Muhammad E, Carmelia R, Yuliati Y, Lubis I, Manoeroeng S. Characteristic of immune response of hepatitis B immunization on infants with two different schedules. PI [Internet]. 30Aug.2006 [cited 19Apr.2024];41(7-8):197-01. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1076
Issue
Vol 41 No 7-8 (2001): July 2001
Section
Articles

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Received 2016-11-23
Accepted 2016-11-23
Published 2006-08-30